ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-1.09%
US Tech 100
20,778.00
-0.69%
S&P 500
6,040.53
-0.50%
US Dollar vs CAD
1.45415
0.01%
Bitcoin
99,633.54
-1.03%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Greenwich LifeSciences Inc (GLSI) Share Price

Greenwich LifeSciences Inc

Greenwich LifeSciences Inc (GLSI)

NASDAQ
12.94
-0.25
(-1.90%)
Closed February 01 3:00PM
Delayed by 15 minutes
12.96
0.02
(0.15%)
After Hours: 6:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
12.94
Bid
10.02
Ask
13.46
Volume
30,219
12.90 Day's Range 13.60
8.00 52 Week Range 21.44
Market Cap
170.092M
Previous Close
13.19
Open
13.11
Last Trade
2
@
13.24
Last Trade Time
Financial Volume
US$ 399,514
VWAP
13.2206
Average Volume (3m)
34,677
Shares Outstanding
13,144,653
Dividend Yield
-
PE Ratio
-19.16
Earnings Per Share (EPS)
-0.68
Revenue
-
Net Profit
-8.89M

About Greenwich LifeSciences Inc

Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.greenwichlifesciences.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Greenwich LifeSciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLSI. The last closing price for Greenwich LifeSciences was US$13.19. Over the last year, Greenwich LifeSciences shares have traded in a share price range of US$ 8.00 to US$ 21.44.

Greenwich LifeSciences currently has 13,144,653 shares outstanding. The market capitalization of Greenwich LifeSciences is US$173.38 million. Greenwich LifeSciences has a price to earnings ratio (PE ratio) of -19.16.

Ask ADVFN Intelligence (AI)

GLSI Latest News

More News

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe 

STAFFORD, Texas, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

January 29 2025
GlobeNewswire Inc.

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

STAFFORD, Texas, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

January 27 2025
GlobeNewswire Inc.

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 

STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

January 23 2025
GlobeNewswire Inc.

Greenwich LifeSciences Provides Update on Commercial Manufacturing

STAFFORD, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

January 22 2025
GlobeNewswire Inc.

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

STAFFORD, Texas, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

January 14 2025
GlobeNewswire Inc.

Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France 

STAFFORD, Texas, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

January 13 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

January 08 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 07 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 03 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 02 2025
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-0.4615384615381314.4112.563388613.2126524CS
41.139.5681625740911.8114.4711.54287012.83531399CS
12-1.01-7.2401433691813.9515.4710.523467712.95005638CS
26-2.98-18.718592964815.9216.510.523217013.58114561CS
52444.74272930658.9421.4484049314.46030958CS
156-4.78-26.975169300217.7226.276.82416178712.43948874CS
2607.94158.85158.073.26214095135.95714946CS

GLSI - Frequently Asked Questions (FAQ)

What is the current Greenwich LifeSciences share price?
The current share price of Greenwich LifeSciences is US$ 12.94
How many Greenwich LifeSciences shares are in issue?
Greenwich LifeSciences has 13,144,653 shares in issue
What is the market cap of Greenwich LifeSciences?
The market capitalisation of Greenwich LifeSciences is USD 173.38M
What is the 1 year trading range for Greenwich LifeSciences share price?
Greenwich LifeSciences has traded in the range of US$ 8.00 to US$ 21.44 during the past year
What is the PE ratio of Greenwich LifeSciences?
The price to earnings ratio of Greenwich LifeSciences is -19.16
What is the reporting currency for Greenwich LifeSciences?
Greenwich LifeSciences reports financial results in USD
What is the latest annual profit for Greenwich LifeSciences?
The latest annual profit of Greenwich LifeSciences is USD -8.89M
What is the registered address of Greenwich LifeSciences?
The registered address for Greenwich LifeSciences is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Greenwich LifeSciences website address?
The website address for Greenwich LifeSciences is www.greenwichlifesciences.com
Which industry sector does Greenwich LifeSciences operate in?
Greenwich LifeSciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.58M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.91M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.93k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
900.48k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.42M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.54M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
338.75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.29M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
234.8M

GLSI Discussion

View Posts
Monksdream Monksdream 5 months ago
GLSI under $20
👍️0
Monksdream Monksdream 10 months ago
GLSI 10Q due 4/3
👍️0
Monksdream Monksdream 10 months ago
GLSI 10Q due 3/27
👍️0
Monksdream Monksdream 11 months ago
GLSI new 52 week hi
👍️0
CassieW CassieW 11 months ago
FYI the share price has essentially doubled since I posted this.
👍️0
CassieW CassieW 11 months ago
This post didn’t age so well, did it?
Heheh
👍️0
CassieW CassieW 1 year ago
https://x.com/crypto_biotech/status/1716889446581522645?s=46&t=pcCxweR8CEspOpPNhjUZdw
👍️0
McMagyar McMagyar 3 years ago
I like how greenwhich is raising money in stock sales..
Not giving insiders discount to market..

Same way Anavex does it..

You don’t want to be diluted?
Buy more. .. I think it’s fair
👍️0
NYCPuglet NYCPuglet 3 years ago
Amazing how that pump and dump worked. What a scam.
👍️0
DiviningRod DiviningRod 4 years ago
New to GLSI. WTF happened last night/ this morning? -20% on good news...?
👍️0
dinogreeves dinogreeves 4 years ago
Yes I see brother, wait till BCT*X announces theirs during their presentation tomorrow at 8:30 AM. GLS*S paving the way for breast cancer.
👍️0
crudeoil24 crudeoil24 4 years ago
GLSI has announced the abstract results of the final 5-year immune response data of the Phase 2b trial at the 2021 AACR Annual Meeting.
The company plans to publish the poster, the abstract, and an audio recording tomorrow in a joint press release.
Potent immune response data, supports the previously reported clinical outcome of 0% metastatic breast cancer recurrences over five years of follow-up.
A statistically significant peak immunity was reached after six months of GP2 treatment as measured in both a GP2 specific CD8 T cell dimer binding assay and a delayed-type-hypersensitivity (DTH) skin test.
HER2 3+ population immune response was similar to the HER2 1-2+ population immune response, suggesting the potential to treat the HER2 1-2+ population with GP2 immunotherapy in combination with trastuzumab (Herceptin) based products and other clinically active agents.
GP2 is immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.
👍️0
ipo_dude ipo_dude 4 years ago
https://www.abstractsonline.com/pp8/#!/9325/presentation/5254

tomorrow she runs,, abstract posted for GLSI
👍️0
dinogreeves dinogreeves 4 years ago
Interesting read here.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163047099
👍️0
FatStrat FatStrat 4 years ago
Great move lol
👍️0
doc063 doc063 4 years ago
It might be resurrected...Who knows?
👍️0
OneDay4488 OneDay4488 4 years ago
Looking good
👍️0
OneDay4488 OneDay4488 4 years ago
Is today the day we break $40 PPS and sustain ?
👍️0
OneDay4488 OneDay4488 4 years ago
5 year 0% reoccurrence for breast cancer. Greenwich LifeSciences. This is remarkable and what the whole world has been waiting for. $100 PPS near term?
👍️ 1
OneDay4488 OneDay4488 4 years ago
Only 12mill share OS!! https://www.otcmarkets.com/stock/GLSI/security
👍️0
OneDay4488 OneDay4488 4 years ago
Agree. Was this little pop today a sign ?
👍️0
OneDay4488 OneDay4488 4 years ago
Agree this is a take over candidate !! Whatever ran this $100 plus recently can do it again ?
👍️0
tbonaces80 tbonaces80 4 years ago
Pfizer will be according to our desks
👍️0
Burg32 Burg32 4 years ago
It was nuts. This Is a great trading stock to build your core position. Lot of potential here but not much for near term catalyst unless they partner.
👍️0
TruckingAngler TruckingAngler 4 years ago
What the heck GLSI ?!!!
I was tired of this sitting, and expecting a pull back market wide so sold 750 shares at 2:08pm today 1/7 for $34.82 at $1.10 loss per share...
I blink my eye & within 40 minutes its over $42 ? !!!
👍️0
OneDay4488 OneDay4488 4 years ago
Can we see $100 plus again in the near future?
👍️0
sanderburwil sanderburwil 4 years ago
Pfizer is my guess- 5 year 0% reoccurrence for breast cancer. Greenwich LifeSciences. This is remarkable and what the whole world has been waiting for. Will continue to add all the way, I see at the very least $150-$200 ahead which is still a fraction of market share who ever will buy them to capitalize on. We’re talking a 10-15+ Billion dollar space and unmet demand here.
2021 will be a prosperous year for all holders here
👍 1
NYCPuglet NYCPuglet 4 years ago
I am a complete idiot for falling for that one. What a joke. What a scam. Pump and Dump. The SEC doesn’t exist. If they did, this shit wouldn’t fly. Classic pump scheme.
👍️0
Harbor6460 Harbor6460 4 years ago
The stock was 3.28 that morning. You paid 100. This market is doomed I e been saying it for months.
👍️0
geminiflyguy geminiflyguy 4 years ago
Does anyone know was there a recent R/S on this stock?
👍️0
sanderburwil sanderburwil 4 years ago
$75-$100- patience- this will be huge and what a market space they’ll capitalize
👍️0
OneDay4488 OneDay4488 4 years ago
Take a look at HGEN.. I m late to the party here but bought in at $38
👍️0
98beamer 98beamer 4 years ago
I would like to have a little fun today. Best case scenario, what is the possible cash per share value of Anavex with multiple SOC indications?
👍️0
Pranner Pranner 4 years ago
I agree.
👍️0
sanderburwil sanderburwil 4 years ago
Add what you can here and take advantage. Float is micro low and now they are funded to moved ahead with approx 27 million cash. If tutes are willing to pay $43-$44, one can only imagine how easily they spike this up when they’re ready. We’re talking 5-7 BILLION market share this company’s drug will be able to capture ahead
Add all you can $40-$50 levels and wait for $80-$100 down road
$GLSI
👍️0
maryj55555 maryj55555 4 years ago
Man.. gotta imagine those in at the low cashed in big time then shorted this thing back down for a double dip.

Crazy
👍️0
JJPow JJPow 4 years ago
Ok so what is the general consensus on where this stock is going moving forward?
👍️0
Paulhallett Paulhallett 4 years ago
I feel your pain.
👍️0
NYCPuglet NYCPuglet 4 years ago
Got stuck in the halt drama.

Got 100 at $100

Can’t believe I fell for this POS.

10 grand goodbye. FML.
👍️0
ClayTrader ClayTrader 4 years ago
* * $GLSI Video Chart 12-11-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
MD3 MD3 4 years ago
Looks like the big boys cashed their tickets and are tanking her back down to single digits
👍️0
Paulhallett Paulhallett 4 years ago
Hopefully it bounces back
👍️0
INFINITI INFINITI 4 years ago
Going to be a Green Day here MARK IT $$$$
👍️0
Paulhallett Paulhallett 4 years ago
Not looking good today again for the peeps that bought high.
👍️0
ClayTrader ClayTrader 4 years ago
* * $GLSI Video Chart 12-10-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
The Wings Of Man The Wings Of Man 4 years ago
It could bounce back up in the afternoon, IMO.
👍️0
Pt3 Pt3 4 years ago
yes every 15min
👍️0
biotechnician biotechnician 4 years ago
Imo. Robinhooders will find NWBO since data lock on phase 3 will be released soon in brain cancer and they are finding AVXL for Alzheimers, Parkinson and Rett.
👍️0
hondaboost hondaboost 4 years ago
Amazing, keeping going up! My investments increasing by 2000%!!!
👍️0
spiderspawnx spiderspawnx 4 years ago
Was halted most of the day yesterday. Looks that way again today.
👍️0

Your Recent History

NASDAQ
GLSI
Greenwich LifeSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads